Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

POM stock hub

Pomdoctor Limited has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

POMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

POM

In the news

Latest news · POM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All POM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

170

Groups with data

Currency

CNY

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001877971
Company name	Pomdoctor Limited
Country	China
Country code	US
Cusip	73181R108
Employees	156
Employees Change	-4%
Employees Change Percent	-2.5
Enterprise value	$71.7M
Exchange	NASDAQ
Financial currency	CNY
First seen	2026-05-09
Industry	Pharmaceutical Retailers
IPO Date	2025-10-08
Isin	US73181R1086
Last refreshed	2026-05-10
Market cap	$8.9M
Market cap category	Nano-Cap
Price	$0.08
Price currency	USD
Rev Per Employee	328,273.85x
Sector	Healthcare
Sic	5900
Symbol	POM
Website	https://www.7lk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-233.99%
EV/Sales	1.4x
FCF yield	-33.95%
P/S ratio	0.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.11%
EBITDA Margin	-7.07%
Gross margin	14.08%
Gross Profit	$7.2M
Gross Profit Growth	18.79%
Gross Profit Growth Q	44.72%
Gross Profit Growth3 Y	-1.29%
Net Income	$-20.8M
Net Income Growth Years	1%
Pretax Margin	-40.59%
Profit Margin	-40.59%
Profit Per Employee	$-133,239
ROA	-32.56
Roa5y	-59.06
ROCE	16.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	1
Revenue Growth	12.13x
Revenue Growth Q	16.19x
Revenue Growth Years	1x
Revenue Growth3 Y	37.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$7.33
Assets	$6.1M
Cash	$802,226
Current Assets	$5.1M
Current Liabilities	$29.3M
Debt	$63.7M
Equity	$-72.5M
Interest Coverage	-1.97
Liabilities	$78.6M
Long Term Assets	$1.1M
Long Term Liabilities	$49.4M
Net Cash	$-62.9M
Net Cash By Market Cap	$-708
Tangible Book Value	$-326M
Tangible Book Value Per Share	$-8.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.17
Inventory Turnover	31.33
Net Working Capital	$-11M
Quick ratio	0.09
Working Capital	$-23M
Working Capital Turnover	$-0.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-56.11%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	0.34
All Time High	6.43
All Time High Change	-98.83%
All Time High Date	2025-11-06
All Time Low	0.06
All Time Low Change	15.56%
All Time Low Date	2026-05-08
ATR	0.09
Beta1y	2.53
Ch YTD	-74.57
High	0.53
High52	6.43
High52 Date	2025-11-06
High52ch	-98.83%
Low	0.06
Low52	0.06
Low52 Date	2026-05-08
Low52ch	15.56%
Ma50ch	-77.67%
Premarket Change Percent	-3.18
Premarket Price	$0.51
Premarket Volume	50,573
RSI	31.9
RSI Monthly	0
RSI Weekly	30.87
Sharpe ratio	-0.53x
Sortino ratio	-0.63
Total Return	-56.11%
Tr YTD	-74.57
Tr1m	-73.13%
Tr1w	-80.27%
Tr3m	-67.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-3.6M
Operating margin	-7.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46,494,920%
Float Percent	39.26%
Net Borrowing	1,858,271.5
Shares Insiders	21.83%
Shares Institutions	0.67%
Shares Out	118,442,191
Shares Qo Q	-26.44%
Shares Yo Y	56.11%
Short Float	0.5%
Short Ratio	0.26
Short Shares	0.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-3M
Average Volume	3,077,717.2x
Bv Per Share	-8.61
CAPEX	$-3,086
Ch1m	-73.13
Ch1w	-80.27
Ch3m	-67.53
Ch6m	-98.6
Change	-85.88%
Change From Open	-85.29
Close	0.53
Days Gap	-3.97
Depreciation Amortization	19,778.6
Dollar Volume	1,615,288.9
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-3.6M
EBITDA	$-3.6M
EPS	$-0.55
F Score	3
FCF	$-3M
FCF EV Yield	-4.2x
FCF Per Share	$-0.03
Financing CF	1,960,133
Fiscal Year End	December
Founded	2,015
Investing CF	-73,664
Ipr	-98.13
Iprfo	-98.33
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2025-12-03
Last Report Date	2025-06-30
Last Split Type	Never
Ma20	0.38
Ma20ch	-80.25%
Net CF	-972,568
Next Earnings Date	2026-05-22
Open	0.51
Optionable	No
Position In Range	2.17
Post Close	0.08
Postmarket Change Percent	-2.67
Postmarket Price	$0.07
Ppne	57,950.1
Pre Close	0.53
Price Date	2026-05-08
Relative Volume	7x
Revenue	51,210,721x
Tr6m	-98.6%
Views	75
Volume	21,537,185
Z Score	-72.63

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does POM pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns POM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.7%

Float: +39.3% of shares outstanding

Insider ownership

+21.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

POM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.9

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About POM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current POM stock rating?

Pomdoctor Limited is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full POM analysis?

The full report lives at /stocks/POM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for POM?

The latest report frames POM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the POM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.